Strategic Positioning BioSistemika’s focus on custom software for laboratory interfacing, data management, and IVD/IEC 62304 compliant solutions positions it as a with-life-science software partner capable of enabling instrument manufacturers and labs to achieve interoperability and compliant digitalization.

collaboration Network Established partnerships with leading Life Science players (Gilson, Agilent, ADInstruments, Alifax, 4titude) and a track record of grant-funded R&D collaborations suggest opportunities for co-development, integration projects, and joint go-to-market activities.

Innovation Spotlight Award-winning DATANA synthetic DNA data storage technology and recent Podim Pitching Competition top prize highlight BioSistemika’s differentiating IP and storytelling that can be leveraged to attract customers seeking cutting-edge digital storage and data management capabilities.

Growth Signals While revenue is under one million, the company has an experienced project management backbone and back office, plus a decade of domain-specific expertise, making it a viable partner for mid to large-scale software modernization, lab automation, and data analytics initiatives.

Market Entry Levers Smaller-scale lab software vendors and instrument manufacturers looking to modernize workflows, enable interoperability, or pursue ISO 13485/IEC 62304-compliant software would benefit from BioSistemika’s proven capabilities, offering a pathway for upsell into existing customer ecosystems.